0001193125-13-298910.txt : 20130723 0001193125-13-298910.hdr.sgml : 20130723 20130723162859 ACCESSION NUMBER: 0001193125-13-298910 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130723 DATE AS OF CHANGE: 20130723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iroko Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001566717 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-36022 FILM NUMBER: 13981658 BUSINESS ADDRESS: STREET 1: ONE KEW PLACE STREET 2: 150 ROUSE BOULEVARD CITY: PHILADELPHIA STATE: PA ZIP: 19112 BUSINESS PHONE: 267-546-3003 MAIL ADDRESS: STREET 1: ONE KEW PLACE STREET 2: 150 ROUSE BOULEVARD CITY: PHILADELPHIA STATE: PA ZIP: 19112 8-A12B 1 d572589d8a12b.htm FORM 8-A Form 8-A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Iroko Pharmaceuticals Inc.

(Exact name of registrant as specified in its charter)

 

 

 

British Virgin Islands   Not Applicable

(State or other jurisdiction

of incorporation or organization)

  

(I.R.S. Employer

Identification No.)

One Kew Place, 150 Rouse Boulevard

Philadelphia, PA

   19112
(Address of principal executive offices)   (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be registered

  

Name of each exchange on which each class is to be registered

Ordinary Shares, par value $0.01   The NASDAQ Stock Market LLC

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.  x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.  ¨

Securities Act registration statement file number to which this form relates (if applicable): 333-189428

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1. Description of Registrant’s Securities to be Registered.

The securities to be registered hereby are ordinary shares, par value $0.01, of Iroko Pharmaceuticals Inc. (the “Registrant”). The information required by this Item 1 is set forth under the heading “Description of Share Capital” contained in the Registrant’s Registration Statement on Form F-1 (File No. 333-189428) under the Securities Act of 1933, as amended (as amended from time to time, the “Registration Statement”), which information is hereby incorporated herein by reference. The description of share capital will also appear in the Registrant’s prospectus that forms a part of the Registration Statement to be filed separately by the Registrant pursuant to Rule 424(b) under the Securities Act of 1933, as amended, and such prospectus is incorporated herein by reference.

 

Item 2. Exhibits.

Not applicable.

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

Date: July 23, 2013

 

IROKO PHARMACEUTICALS INC.
By:   /s/ Moji James
Name:   Moji James
Title:   Senior Vice President, General Counsel and Secretary